JOSEPH KAGAN: Open Payments
NPI 1851388029 · BROCKTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,268 in 175 payments from 35 companies in 2025. Trend: 2023 $2,795 · 2024 $3,090 · 2025 $3,268
Food & beverage: $3,268
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 18 | $419 |
| PFIZER INC. | 22 | $366 |
| Lilly USA, LLC | 18 | $342 |
| ABBVIE INC. | 23 | $294 |
| Novo Nordisk Inc | 11 | $240 |
| Novartis Pharmaceuticals Corporation | 14 | $209 |
| Esperion Therapeutics, Inc. | 12 | $136 |
| TOLMAR, INC. | 4 | $115 |
| Sumitomo Pharma America, Inc. | 4 | $94 |
| Lundbeck LLC | 4 | $87 |
Products named: VRAYLAR, LEQVIO, JARDIANCE, NURTEC ODT, FARXIGA, AIRSUPRA, NEXLETOL, REXULTI.
Industry payments across MA — which companies pay providers there.
